Nebivololo E Idroclorotiazide Doc Generici (Hydrochlorothiazide, Nebivolol)

Nebivolol/Hydrochlorothiazide, the active ingredient in Nebivololo E Idroclorotiazide Doc Generici, is a beta blocker and thiazide diuretic presented as a tablet for oral use. It treats hypertension in adult patients.

GNH USA supplies Nebivololo E Idroclorotiazide Doc Generici as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol/Hydrochlorothiazide is indicated for the management of hypertension, a condition characterized by elevated arterial pressure.

- Hypertension: lowers systolic and diastolic blood pressure and reduces cardiovascular risk. - Primary (essential) hypertension: provides effective control when monotherapy is insufficient. - Combination therapy in adults: offers a convenient single‑tablet option for patients requiring both a beta blocker and a thiazide diuretic.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often transient. - Dizziness: sensation of light‑headedness, especially on standing. - Fatigue: generalized tiredness. - Cough: dry or productive. - Nausea: mild stomach upset. - Increased urination: due to diuretic action.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Electrolyte imbalance: notably low potassium or sodium levels. - Gout flare: increased uric acid leading to joint pain. - Pancreatitis: abdominal pain with elevated enzymes. - Allergic reactions: rash, itching, or swelling. - Renal impairment: reduced kidney function.

Patients should be evaluated for specific risk factors before initiating therapy.

- Monitor blood pressure: ensure target levels are achieved without excessive drop. - Assess electrolytes: check potassium and sodium regularly. - Evaluate renal function: baseline and periodic creatinine measurements. - Use caution in diabetes: diuretics may affect glucose control. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Nebivolol/Hydrochlorothiazide may interact with several drug classes.

Major Interactions (Avoid): - Other antihypertensives: risk of additive hypotension. - Potassium‑sparing diuretics: may cause hyperkalemia. - NSAIDs: can diminish diuretic efficacy and affect renal function. - Lithium: increased lithium levels and toxicity. - CYP2D6 inhibitors: elevate nebivolol concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and potassium. - Additional beta blockers: risk of excessive β‑blockade. - Corticosteroids: may counteract antihypertensive effect. - Antidiabetic agents: monitor glucose as diuretics may raise blood sugar. - Antidepressants (tricyclics): potential additive cardiac effects.